Citric acid and compound citric acid application in pharmacy

A technology of citric acid and composition, applied in the application field of citric acid in pharmaceuticals, can solve the problems of lack of vaccines, etc., achieve the effects of ensuring food safety, improving competitiveness, and solving food antibiotic residues

Active Publication Date: 2012-07-18
四川通达动物保健科技有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In 2005, the Ministry of Agriculture issued a document prohibiting the application of broad-spectrum drugs (viralin, amantadine, rimantadine, acyclovir) used by humans to livestock and poultry drugs to prevent the transfer of antiviral drug resistance from livestock to humans However, some infectious diseases in my country still lack effective vaccines to control (such as respiratory reproductive syndrome, porcine myocarditis, pig unknown high fever, etc.), so it is urgent to develop effective drugs to prevent these diseases
[0010] There is no report about the use of citric acid drug compound for anti-viral or anti-bacterial diseases in livestock and poultry

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Citric acid and compound citric acid application in pharmacy
  • Citric acid and compound citric acid application in pharmacy
  • Citric acid and compound citric acid application in pharmacy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] The compound citric acid of the invention comprises the following components: 94.5 grams of citric acid, 3.0 grams of guaifenesin, and 2.5 grams of sulfoethylamine. Its preparation process is as follows:

[0035] Each component is weighed according to the above weight, pulverized and passed through an 80-mesh sieve, mixed evenly, and divided into bottles to obtain powder.

Embodiment 2

[0037] The compound citric acid of the present invention comprises the following components: 93 grams of citric acid, 4 grams of guaifenesin, and 3 grams of sulfoethylamine.

[0038] Its preparation process is as follows:

[0039] Each component is weighed according to the above weight, pulverized and passed through an 80-mesh sieve, mixed evenly, and divided into bottles to obtain powder.

Embodiment 3

[0041] The compound citric acid of the present invention comprises the following components: 97.5 grams of citric acid, 1 gram of guaifenesin, and 1.5 grams of sulfoethylamine.

[0042] Its preparation process is as follows:

[0043] Each component is weighed according to the above weight, pulverized and passed through an 80-mesh sieve, mixed evenly, and divided into bottles to obtain powder.

[0044] The compound citric acid powder used in the following experimental example is the compound citric acid powder obtained in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a new usage of citric acid and compound citric acid in the field of pharmacy. The product can prevent and control viral diseases and bacterial diseases of livestock and poultry; wherein, the compound citric acid comprises the following components according to weight portion: 93-98 portions of citric acid, 0.5-4 portions of gualfenesin and 1.5-3 portions of etamsylate. Proved by in vivo and vitro experiments, the compound citric acid can play a role in preventing and controlling fowl mycoplasma gallisepticum, avian influenza (H9 subtype), bursal virus disease and otherdiseases, and can effectively kill animal pathogenic bacterias such as cattle colon bacillus, mycoplasma gallisepticum, chicken colibacillosis, etc.

Description

technical field [0001] The invention relates to the application of citric acid in pharmacy, in particular to the application of a citric acid compound in resisting bursal disease and respiratory diseases caused by livestock and poultry viruses or bacteria. Background technique [0002] In recent years, as the safety of animal products has attracted more and more attention from consumers, the production of pollution-free animal products has become an inevitable trend in the development of animal husbandry. Developed countries are becoming more and more strict with the registration and management of veterinary drugs. The European Union announced in 2006 that antibiotics would no longer be used as production-promoting additives, and many veterinary drugs were banned. Several types of green additives such as enzymes, prebiotics, and Chinese herbal medicines have become the focus of veterinary drug manufacturers. In particular, the new veterinary drug products with low residue a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/194A61K31/09A61K31/131A61K31/095A61P31/12A61P31/16A61P31/04
Inventor 何诚张发明栗绍文李应超李树梅
Owner 四川通达动物保健科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products